Page 114 - JSOM Spring 2020
P. 114

o Reassess the MWD after each 500mL IV/IO   *NOTE: Ketamine can cause nystagmus and increased intra-
                     bolus.                                  ocular pressure in an MWD. Therefore consider alternative
                     o Continue resuscitation until a palpable femoral   sedatives or analgesics in MWDs with penetrating eye traumas
                     pulse, improved mental status, or systolic BP of   unless other alternatives are unavailable or are ineffective.
                     80–90mmHg is present.                     9.  Monitoring
                     o Discontinue fluid administration when one or   a.  Initiate  advanced electronic  monitoring,  if indicated
                     more of the listed end points has been achieved.  and if monitoring equipment is available.
               ■   If an MWD with an altered  mental status due to   b.  Monitors of choice include pulse oximetry (placed
                  suspected TBI has a weak or absent femoral pulse,   on the lip, tongue, or prepuce) and capnography, if
                  resuscitate as necessary to restore and maintain a   intubated.
                  normal femoral pulse. If BP monitoring is available,   10.  ANALGESIA
                  maintain a target systolic BP of ≥90mmHg.      a.  Analgesia on the battlefield should generally be
               ■   Reassess the MWD frequently to check for recurrence   achieved using one of three options:
                  of shock. If shock recurs, recheck all external hem-  Option 1
                  orrhage control measures to ensure they are still ef-  ■  Mild to Moderate Pain
                  fective and repeat the fluid resuscitation as outlined.    o Meloxicam: one-half of a 7.5mg tablet (0.1mg/
               ■   Refractory Shock                                     kg) orally once a day
                     o If an MWD in shock is refractory to fluid re-    o DO NOT give acetaminophen (e.g., Tylenol) or
                     suscitation and canine blood products are not      ibuprofen to an MWD.
                     available, consider:                          Option 2
                                                   ®
                     ◆   Using  synthetic  colloids  (Hextend   [Pfizer,   ■  Moderate to Severe Pain
                       https://www.pfizer.com/] and/or Hespan  [B.   MWD is NOT in shock or respiratory distress
                                                      ®
                       Braun Medical Inc. https://www.bbraunusa.     AND MWD is NOT at significant risk of develop-
                       com/en.html) – 150–200mL bolus IV/IO.         ing either condition:
                       Can repeat if shock state is not resolved.       o Do not attempt to give oral transmucosal fen-
                     o Untreated tension pneumothorax as a possible     tanyl citrate to an MWD. Rather, administer
                     cause  of refractory  shock. Thoracic  trauma,     ONE of the following options:
                     persistent respiratory distress, absent breath     ◆   Morphine: 0.25–0.5mg/kg  IM (equivalent
                                                                                               33
                     sounds, and hemoglobin oxygen saturation             to one 10mg morphine autoinjector), or
                     <90% support this diagnosis. Treat as indicated    ◆   Hydromorphone: 0.1mg/kg  IV/IO/IM, or
                                                                                                33
                     above with repeated C-NDC or finger thoracos-      ◆   Fentanyl (injectable) every 20–30 minutes at:
                     tomy/chest tube insertion.  Note: If finger tho-     2–5µg/kg IV/IO,  or 10µ/kg  IM, or 4µ/kg
                                                                                                 33
                                                                                       33
                     racostomy is used, it may not remain patent and      intranasally (IN). 34
                     finger decompression through the incision may   *NOTE: Morphine and hydromorphone often cause vomiting
                     have to be repeated. In MWDs, always consider   in dogs, so handlers and medics should be prepared to remove
                     decompressing both sides of the chest as de-  the muzzle after administration of an opioid. Hydromorphone
                     scribed in Section 5.                   causes excessive panting; use caution with head injuries and
          7.  Hypothermia Prevention                         respiratory disease.
            a.  Minimize MWD’s exposure to the elements.           Option 3
            b.  Remove any wet outer wear (e.g., vests, harnesses, boo-  ■  Moderate to Severe Pain
               ties). GENTLY pat dry any wet tissues or hair coat.   MWD is in hemorrhagic shock or respiratory dis-
            c.  Place the MWD on an insulated surface as soon as     tress OR MWD is at significant risk of developing
               possible.                                             either condition:
            d.  Apply a ready-heat blanket from the HPMK to the         o Ketamine: 2–5mg/kg (60–90mg) IV/IO/IM/IN 13,35
               MWD’s torso (not directly on the skin) and cover the     o If possible, to improve analgesia or sedation,
               MWD with the heat-reflective shell (HRS).                strongly consider combination therapy when-
            e.  If an HRS is not available, the combination of the      ever using ketamine in MWDs. Suggested proto-
               Blizzard Survival Blanket (Blizzard Protection Systems   cols include combining 50mg of ketamine with
               Ltd., https://www.blizzardsurvival.com/) and a ready-    either an/a:
               heat blanket may also be used.                           ◆   Opioid (5mg of morphine OR 3mg of hydro-
            f.  If these items are not available, use dry blankets, pon-  morphone OR 150µg fentanyl), OR
               cho liners, sleeping bags, or anything that will retain   ◆   Benzodiazepine (10mg of midazolam or
               heat and keep the MWD dry.                                 diazepam). 13,36
            g.  Warm fluids are preferred if IV/IO fluids are required.  *End points: Control of pain and appropriate level of seda-
          8.  Penetrating Eye Trauma                         tion. MWD should be generally recumbent but responsive and
            a.  If a penetrating eye injury is noted or suspected:  breathing voluntarily and comfortably.
               ■   Place muzzle on MWD, if practical, before exam-  Analgesia Notes:
                  ining the eye.                                 a.  Document mental status in MWD before administer-
               ■   DO NOT attempt to bandage or cover the eye. Make   ing opioids or ketamine.
                  every effort to prevent MWD from scratching at the   b.  For all casualties given opioids or ketamine, monitor
                  eye. Consider sedation as outlined in Section 10.  airway, breathing, and circulation closely.
               ■   If possible, gently rinse the eye with clean water.  c.  Consider adjunct administration of antiemetics (on-
               ■   Ensure that oral or IV or intramuscular (IM) antibi-  dansetron 8–16mg IV or 24mg orally) 37,38  before ad-
                  otics are given as outlined under Antibiotics.   ministering opioids.


          108  |  JSOM   Volume 20, Edition 1 / Spring 2020
   109   110   111   112   113   114   115   116   117   118   119